News

Applied StemCell demonstrates efficient knock-in of a 50 kb DNA construct into human iPSCs using TARGATT™ technology November 11, 2025 8:00 AM PST Milpitas, CA — Applied StemCell, Inc. (ASC),

Celebrating our growing Business Development team September 17, 2025 11:00 AM PST We’re thrilled to welcome Kaytrina Anchelia as a Director of Business Development. With nearly a decade of experience

Applied StemCell Appoints Dolores Baksh, Ph.D., as Chief Executive Officer August 21, 2025 10:00 AM PST Applied StemCell, a genome engineering product and services company, announced today the appointment of

Our two new hypoimmunogenic hiPSC products are here to accelerate your allogeneic therapies May 20, 2025 8:30 AM PST We are thrilled to announce the launch of our first hypoimmunogenic

Announcing our Drug Master File Submission to the US FDA for our GMP-Grade iPSC Cell Line April 14, 2025 12:00 PM PST We are thrilled to announce that we have

Applied StemCell’s Brand Refresh: Building the biology-based future January 30, 2025 12:00 PM PST Drug discovery is a famously challenging endeavor, with a 96% failure rate, a $1B+ price tag